Form 4: Bed Bath & Beyond Director Sells Shares Under 10b5-1 Plan

Joanna M. Burkey, a Director at Bed Bath & Beyond, Inc., reported the sale of 9,943 shares of common stock for approximately $6.38 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Joanna M. Burkey, a Director of Bed Bath & Beyond, Inc. (BBBY), sold 9,943 shares of common stock on June 4, 2026.
• The sale was conducted under a Rule 10b5-1 trading plan, adopted on March 5, 2026, which allows for pre-scheduled transactions.
• The shares were sold at a weighted average price of $6.38, with individual transactions ranging from $6.38 to $6.40 per share.
• Following the transaction, Burkey beneficially owns 32,474 shares of common stock directly.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative sentiment due to an insider selling shares, despite the transaction being executed under a pre-arranged plan.

Negatives

• Director Joanna M. Burkey sold a portion of her holdings in Bed Bath & Beyond.
• The sale of 9,943 shares reduces the direct beneficial ownership of a company director.

Risks

• The sale of shares by a director, even under a 10b5-1 plan, could be interpreted negatively by the market, potentially impacting investor sentiment.
• The company's financial health and future prospects, which may have influenced the director's decision to sell, are not detailed in this filing.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance. It solely reports a transaction by a director.

Management Comments

• The sale reported in this Form 4 was effected pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.
• The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.38 to $6.40 per share, inclusive.
• The reporting person will provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

Industry Context

StockSavvy.ai notes that insider sales, even those conducted under Rule 10b5-1 plans, are closely watched by the market. While these plans are designed to avoid accusations of insider trading by establishing a predetermined schedule for sales, they can still influence investor perception of management's confidence in the company's future. For a company like Bed Bath & Beyond, which has faced significant market challenges, any insider selling activity warrants attention.

Stakeholder Impact

• Shareholders may view the director's sale as a signal of reduced confidence, potentially impacting share price in the short term.
• The sale does not directly impact employees, customers, suppliers, or creditors based on the information provided in this filing.

Next Steps

• The reporting person may provide further details on share sale prices upon request from regulatory bodies or security holders.

Key Dates

Recommendation

The filing reports a routine insider transaction under a 10b5-1 plan, which is not indicative of a significant change in the company's fundamental value or future prospects. While insider selling can be a negative signal, the pre-arranged nature of this sale mitigates immediate concern. Investors should monitor broader company performance and strategic updates rather than solely this transaction for investment decisions.

Keywords

Bed Bath & Beyond, BBBY, Form 4, Insider Trading, Stock Sale, Director Transaction, Rule 10b5-1, Beneficial Ownership